Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: RMD

ResMed Inc.

Healthcare | Medical - Devices
$209.63 -4.21 (-1.97%) as of 2026-07-15 04:51 UTC
Market Cap$30.4B
Volume1.14M
EPS (TTM)$9.51

ResMed Inc. (NYSE: RMD) is a $30.4B medical - devices company trading at $209.63 (−2.0% today) — 22.0× trailing earnings, yielding 1.01%. Figures from SEC EDGAR and market feeds; updated 2026-07-15 04:51 UTC.

52-Week Range
Low $203.15High $231.99

What ResMed Inc. does

ResMed is a global digital health company that designs cloud-connected medical devices and software to treat chronic respiratory conditions and support residential care. The company pioneered CPAP treatment for obstructive sleep apnea and has since expanded into a range of respiratory devices, diagnostic products, masks, accessories, and cloud-based health applications that help clinicians manage patients and encourage treatment adherence.

Summarized from ResMed Inc.’s SEC filings · Read the filing ↗

Key facts
Quote
Price$209.63
Change (1D)-4.21 (-1.97%)
Market cap$30.4B
Volume1.14M shares
52-week range$203.15 – $231.99
Valuation
P/E (TTM)22.04×
EV/EBITDA15.90×
EPS (TTM)$9.51
Dividend yield1.01%
Price/book5.10×
Return on equity23.47%
Debt/equity0.11
Returns
52-week return+3.2%
Revenue, margins & earnings
FY2021 Net income: $475MFY2021 Taxes & interest: $429MFY2021 Operating expenses: $935MFY2021 Cost of revenue: $1.36B$3.20BFY2021FY2022 Net income: $779MFY2022 Taxes & interest: $221MFY2022 Operating expenses: $1.02BFY2022 Cost of revenue: $1.55B$3.58BFY2022FY2023 Net income: $898MFY2023 Taxes & interest: $234MFY2023 Operating expenses: $1.22BFY2023 Cost of revenue: $1.87B$4.22BFY2023FY2024 Net income: $1.02BFY2024 Taxes & interest: $299MFY2024 Operating expenses: $1.34BFY2024 Cost of revenue: $2.03B$4.69BFY2024FY2025 Net income: $1.40BFY2025 Taxes & interest: $285MFY2025 Operating expenses: $1.37BFY2025 Cost of revenue: $2.09B$5.15BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-07-09
  • 2026-07-09Farrell Michael J.Chairman and CEOM4,991$730.4K
  • 2026-07-09Farrell Michael J.Chairman and CEOSELL-4,991$1.09M
  • 2026-07-09Farrell Michael J.Chairman and CEOM-4,991—
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
Source: SEC EDGAR · As of 2026-Q1
  • VANGUARD GROUP INC18,813,605$4.53B-1.2%
  • BlackRock, Inc.9,749,943$2.19B-21.0%
  • VANGUARD CAPITAL MANAGEMENT LLC9,466,416$2.13BNEW
View QoQ ownership changes →
Company news View all →
Questions this page answers

What does ResMed Inc. do?

ResMed is a global digital health company that designs cloud-connected medical devices and software to treat chronic respiratory conditions and support residential care.

What is RMD's valuation?

RMD trades at $209.63, 22.04× trailing earnings, 15.90× EV/EBITDA, as of 2026-07-15. It carries a 1.01% dividend yield.

When did RMD last file with the SEC?

ResMed Inc.'s most recent SEC filing on record is a 8-K filed 2026-07-07. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-15 04:51 UTC. This page is also available as JSON at /api/data?ticker=RMD and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for RMD and 3,500+ tickers.

Create a free account — keep RMD
For your agent
GET /api/data?ticker=RMD

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt